Condition: Head and Neck Cancer Squamous Cell Carcinoma · Sponsor: Hunan Cancer Hospital
To evaluate the efficacy and safety of trilaciclib combined with standard treatment project as an adjuvant treatment for Head and neck cancer after surgery
This description comes directly from the study's public registry record.
Feng Liu, Doctoral Degree · +86073189762191 · liufeng@hnca.org.cn
Always discuss trial participation with your own doctor first.
| Hunan Cancer hospital | Changsha, Hunan, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06752798